Attached files

file filename
10-K - FORM 10-K - DRUGSTORE COM INCd10k.htm
EX-4.12 - FORM OF RESTRICTED STOCK UNIT AGREEMENT BETWEEN THE COMPANY AND DAWN LEPORE - DRUGSTORE COM INCdex412.htm
EX-21.1 - LIST OF SUBSIDIARIES - DRUGSTORE COM INCdex211.htm
EX-4.11 - FORM OF RESTRICTED STOCK UNIT AGREEMENT - DRUGSTORE COM INCdex411.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - DRUGSTORE COM INCdex231.htm
EX-10.12 - AMENDMENT NO. 2 TO LEASE AGREEMENT - DRUGSTORE COM INCdex1012.htm
EX-10.29 - FORM OF CHANGE IN CONTROL AGREEMENT WITH EXECUTIVE OFFICERS - DRUGSTORE COM INCdex1029.htm
EX-10.27 - OFFER LETTER OF ROBERT POTTER - DRUGSTORE COM INCdex1027.htm
EX-10.25 - AMENDMENT TO LETTER AGREEMENT WITH DAWN LEPORE - DRUGSTORE COM INCdex1025.htm
EX-10.13 - LEASE OF OFFICE SPACE - DRUGSTORE COM INCdex1013.htm
EX-10.28 - OFFER LETTER OF TRACY WRIGHT - DRUGSTORE COM INCdex1028.htm
EX-10.16 - SECOND AMENDMENT TO INDUSTRIAL BUILDING LEASE - DRUGSTORE COM INCdex1016.htm
EX-31.2 - SECTION 302 CERTIFICATION OF CFO - DRUGSTORE COM INCdex312.htm
EX-32.2 - SECTION 906 CERTIFICATION OF CFO - DRUGSTORE COM INCdex322.htm
EX-32.1 - SECTION 906 CERTIFICATION OF CEO - DRUGSTORE COM INCdex321.htm

Exhibit 31.1

CERTIFICATION

I, Dawn G. Lepore, certify that:

 

1. I have reviewed this annual report on Form 10-K of drugstore.com, inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

/s/ Dawn G. Lepore

Dawn G. Lepore

President, Chief Executive Officer and

Chairman of the Board

March 18, 2011